Archives
-
Coronavirus Macrodomains and PARP-Mediated Restriction
2026-10-05
Grunewald et al. show that coronavirus macrodomains counter host PARP-dependent antiviral activity, linking ADP-ribosylation to both viral replication control and interferon induction. The study identifies PARP12 and PARP14 as important contributors in model systems while defining clear limits on how these findings should be transferred to therapeutic or nonviral research contexts.
-
Mouse Genotyping Evidence in SCA3 Research
2026-10-04
A source-grounded overview of how mouse genotyping supports SCA3/MJD studies, what the 2026 iTBS study found, and why those findings do not independently validate any particular genotyping product.
-
Direct Mouse Genotyping Kit Plus: Evidence Beyond PCR
2026-10-03
The Direct Mouse Genotyping Kit Plus can simplify DNA-to-PCR workflows, but its greatest scientific value depends on interpreting genotype evidence correctly. This article connects direct mouse genotyping with lineage-aware research, using a 2024 Kupffer-cell study to clarify what PCR can establish—and what it cannot.
-
Mifepristone (RU486) Research Workflows
2026-10-02
Mifepristone (RU486) is a versatile progesterone receptor antagonist for receptor-aware cancer, reproductive, and tumor-model studies. This guide converts its reported activity into practical formulation, assay-design, optimization, and troubleshooting workflows.
-
X-Gal: From Clone Selection to Translational Insight
2026-10-01
X-Gal remains more than a blue colony reagent: it is a decision point in molecular cloning and a model for how simple, mechanistically grounded readouts can strengthen translational research. This article connects β-galactosidase chemistry, construct validation, and emerging iRhom2 olfaction biology while defining the boundaries of what X-Gal can—and cannot—prove.
-
FAISL Stabilizes FAK in Triple-Negative Breast Cancer
2026-10-01
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis. Its integrated tissue, cell, interaction, and nanoparticle-delivery experiments position FAISL as a regulator of adhesion-dependent TNBC progression and a potential target for metastasis-focused research.
-
Necrostatin-1: RIP1 Kinase Workflow Guide
2026-09-30
Necrostatin-1 is a practical RIP1 kinase inhibitor for separating necroptosis from other forms of stress-induced cell death. This guide combines TNF-α challenge workflows with redox, mitochondrial, liver-injury, and acute kidney injury research applications, including controls and troubleshooting strategies.
-
Cycloastragenol in Glucocorticoid-Induced Osteonecrosis
2026-09-30
This in vivo study identifies osteoclast overactivity as a tractable component of glucocorticoid-induced osteonecrosis of the femoral head and shows that cycloastragenol preserves femoral-head structure in methylprednisolone-treated rats. The findings connect reduced RANKL/OPG imbalance and osteoclast-marker expression with smaller necrotic lesions, better trabecular integrity, and improved local blood supply, while still requiring validation beyond the animal model.
-
FXR–KLF11 Signaling in Contrast-Induced AKI
2026-09-29
This 2026 study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3-driven inflammation and apoptosis. Its combination of mouse modeling, HK-2 cell experiments, RNA sequencing, promoter assays, chromatin immunoprecipitation, and genetic loss-of-function analysis provides a mechanistic framework for evaluating FXR agonism as a prophylactic strategy.
-
Cdc42–GSK-3β Signaling in Kidney Fibrosis
2026-09-29
The reference study identifies the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that acts through Cdc42 and the PKCζ/GSK-3β/β-catenin axis. Its combination of thermal proteome profiling, renal fibroblast assays, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42-centered fibrosis workflows without equating anti-fibrotic activity with effects observed in other cell systems.
-
TMRE Mitochondrial Membrane Potential Assay Kit
2026-09-28
This scenario-driven guide explains how TMRE mitochondrial Membrane Potential Assay Kit, SKU K2233, can support mitochondrial depolarization measurement, apoptosis studies, and high-throughput mitochondrial function analysis. It connects practical assay design with mechanistic evidence on sodium-driven mitochondrial energy failure and emphasizes controls, interpretation, and vendor-selection criteria.
-
CCCP and Mitochondrial Morphology: Assay Logic
2026-09-28
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) collapses mitochondrial proton motive force, but its value in morphology research depends on how carefully researchers separate bioenergetic perturbation from disease-associated phenotype. This article connects uncoupling to deep-learning analysis of urine-derived stem cells and explains practical controls and interpretation limits.
-
Macrophage EP4 Loss Accelerates Atherosclerosis
2026-09-27
A 2025 study links myeloid EP4 deficiency to larger, less stable atherosclerotic plaques, increased macrophage foam-cell formation, and M1 polarization. Transcriptomic and proteomic findings, followed by expression validation, point to CD36 as a candidate mediator of these effects, although its necessity was not established by the reported experiments.
-
Ionomycin Free Acid: Practical Calcium Assays
2026-09-26
Use Ionomycin free acid to create a controlled calcium-transport challenge for live-cell signaling, assay development, and specialized oocyte research. This guide connects practical ionophore workflows with a TNBC study of FAK protein stability—while distinguishing supported findings from hypotheses that still need testing.
-
Ionomycin Free Acid for Calcium-to-FAK Studies
2026-09-25
Use Ionomycin free acid to impose a controlled calcium perturbation while testing how FAISL and FAK protein stability respond in triple-negative breast cancer models. This practical workflow separates rapid intracellular calcium changes from later adhesion and FAK readouts—and treats the proposed calcium-to-FAK connection as a testable hypothesis, not an established result.